Simone Coughlan

Simone Coughlan

Auto-generated profile, based on publicly available information

Simone Coughlan

Research Ireland Centre for Research Training in Genomics Data Science, Galway, Ireland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Gastroenterology
Verified
Journal Article
Open access
IJIan Jeffery
Ian Jeffery
ADAnubhav Das
Anubhav Das
EOEileen O’hErlihy
Eileen O’hErlihy
SCSimone Coughlan
Simone Coughlan
KCKatryna Cisek
Katryna Cisek
POPaul O'Toole
Paul O'Toole
Irritable bowel syndrome (IBS) is a heterogeneous disorder, but diagnoses and determination of subtypes are made based on symptoms. We profiled the fecal microbiomes of patients with and without IBS to identify biomarkers of this disorder. We collected fecal and urine samples from 80 patients with IBS (Rome IV criteria; 16-70 years old) and 65 matched individuals without IBS (control individuals), along with anthropometric, medical, and dietary information. Shotgun and 16S ribosomal RNA amplicon sequencing were performed on feces, whereas urine and fecal metabolites were analyzed by gas chromatography and liquid chromatography-mass spectrometry. Co-occurrence networks were generated based on significant Spearman correlations between data. Bile acid malabsorption (BAM) was identified in patients with diarrhea by retention of radiolabeled selenium-75 homocholic acid taurine. Patients with IBS had significant differences in network connections between diet and fecal microbiomes compared with control individuals; these were accompanied by differences in fecal metabolomes. We did not find significant differences in fecal microbiota composition among patients with different IBS symptom subtypes. Fecal metabolome profiles could discriminate patients with IBS from control individuals. Urine metabolomes also differed significantly between patients with IBS and control individuals, but most discriminatory metabolites were related to diet or medications. Fecal metabolomes, but not microbiomes, could distinguish patients with IBS with vs those without BAM. Despite the heterogeneity of IBS, patients have significant differences in urine and fecal metabolomes and fecal microbiome vs control individuals, independent of symptom-based subtypes of IBS. Fecal metabolome analysis can be used to distinguish patients with IBS with vs those without BAM. These findings might be used for developing microbe-based treatments for these disorders.

23 July 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BNB. Anne Neville
B. Anne Neville
PSPaul O. Sheridan
Paul O. Sheridan
HHHugh M. B. Harris
Hugh M. B. Harris
SCSimone Coughlan
Simone Coughlan
HFHarry J. Flint
Harry J. Flint
POPaul O'Toole
Paul O'Toole
Some Eubacterium and Roseburia species are among the most prevalent motile bacteria present in the intestinal microbiota of healthy adults. These flagellate species contribute “cell motility” category genes to the intestinal microbiome and flagellin proteins to the intestinal proteome. We reviewed and revised the annotation of motility genes in the genomes of six Eubacterium and Roseburia species that occur in the human intestinal microbiota and examined their respective locus organization by comparative genomics. Motility gene order was generally conserved across these loci. Five of these species harbored multiple genes for predicted flagellins. Flagellin proteins were isolated from R. inulinivorans strain A2-194 and from E. rectale strains A1-86 and M104/1. The amino-termini sequences of the R. inulinivorans and E. rectale A1-86 proteins were almost identical. These protein preparations stimulated secretion of interleukin-8 (IL-8) from human intestinal epithelial cell lines, suggesting that these flagellins were pro-inflammatory. Flagellins from the other four species were predicted to be pro-inflammatory on the basis of alignment to the consensus sequence of pro-inflammatory flagellins from the β- and γ- proteobacteria. Many fliC genes were deduced to be under the control of σ28. The relative abundance of the target Eubacterium and Roseburia species varied across shotgun metagenomes from 27 elderly individuals. Genes involved in the flagellum biogenesis pathways of these species were variably abundant in these metagenomes, suggesting that the current depth of coverage used for metagenomic sequencing (3.13–4.79 Gb total sequence in our study) insufficiently captures the functional diversity of genomes present at low (≤1%) relative abundance. E. rectale and R. inulinivorans thus appear to synthesize complex flagella composed of flagellin proteins that stimulate IL-8 production. A greater depth of sequencing, improved evenness of sequencing and improved metagenome assembly from short reads will be required to facilitate in silico analyses of complete complex biochemical pathways for low-abundance target species from shotgun metagenomes.

3 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCSimone Coughlan
Simone Coughlan
PMPeter Mulhair
Peter Mulhair
MSMandy Sanders
Mandy Sanders
GSGabriele Schönian
Gabriele Schönian
JCJames Cotton
James Cotton
TDTim Downing
Tim Downing
Control of pathogens arising from humans, livestock and wild animals can be enhanced by genome-based investigation. Phylogenetically classifying and optimal construction of these genomes using short sequence reads are key to this process. We examined the mammal-infecting unicellular parasite Leishmania adleri belonging to the lizard-infecting Sauroleishmania subgenus. L. adleri has been associated with cutaneous disease in humans, but can be asymptomatic in wild animals. We sequenced, assembled and investigated the L. adleri genome isolated from an asymptomatic Ethiopian rodent (MARV/ET/75/HO174) and verified it as L. adleri by comparison with other Sauroleishmania species. Chromosome-level scaffolding was achieved by combining reference-guided with de novo assembly followed by extensive improvement steps to produce a final draft genome with contiguity comparable with other references. L. tarentolae and L. major genome annotation was transferred and these gene models were manually verified and improved. This first high-quality draft Leishmania adleri reference genome is also the first Sauroleishmania genome from a non-reptilian host. Comparison of the L. adleri HO174 genome with those of L. tarentolae Parrot-TarII and lizard-infecting L. adleri RLAT/KE/1957/SKINK-7 showed extensive gene amplifications, pervasive aneuploidy, and fission of chromosomes 30 and 36. There was little genetic differentiation between L. adleri extracted from mammals and reptiles, highlighting challenges for leishmaniasis surveillance.

25 April 2018 in Royal Society Open Science
Verified
Journal Article
Open access
SCSimone Coughlan
Simone Coughlan
ATAli Shirley Taylor
Ali Shirley Taylor
EFEoghan Feane
Eoghan Feane
MSMandy Sanders
Mandy Sanders
GSGabriele Schönian
Gabriele Schönian
TDTim Downing
Tim Downing
The unicellular protozoan parasiteLeishmaniacauses the neglected tropical disease leishmaniasis, affecting 12 million people in 98 countries. In South America, where theVianniasubgenus predominates, so far onlyL.(Viannia)braziliensisandL.(V.)panamensishave been sequenced, assembled and annotated as reference genomes. Addressing this deficit in molecular information can inform species typing, epidemiological monitoring and clinical treatment. Here,L.(V.)naiffiandL.(V.)guyanensisgenomic DNA was sequenced to assemble these two genomes as draft references from short sequence reads. The methods used were tested using short sequence reads forL. braziliensisM2904 against its published reference as a comparison. This assembly and annotation pipeline identified 70 additional genes not annotated on the original M2904 reference. Phylogenetic and evolutionary comparisons ofL. guyanensisandL. naiffiwith 10 otherVianniagenomes revealed four traits common to allViannia: aneuploidy, 22 orthologous groups of genes absent in otherLeishmaniasubgenera, elevated TATE transposon copies and a high NADH-dependent fumarate reductase gene copy number. Within theViannia, there were limited structural changes in genome architecture specific to individual species: a 45 Kb amplification on chromosome 34 was present in all barL. lainsoni,L. naiffihad a higher copy number of the virulence factor leishmanolysin, and laboratory isolateL. shawiM8408 had a possible minichromosome derived from the 3’ end of chromosome 34.This combination of genome assembly, phylogenetics and comparative analysis across an extended panel of diverseVianniahas uncovered new insights into the origin and evolution of this subgenus and can help improve diagnostics for leishmaniasis surveillance.

14 November 2016 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
EWElaine M. Waters
Elaine M. Waters
JRJustine K. Rudkin
Justine K. Rudkin
SCSimone Coughlan
Simone Coughlan
GCGeremy C. Clair
Geremy C. Clair
JAJoshua N. Adkins
Joshua N. Adkins
JOJim O'Gara
Jim O'Gara
Innovative approaches to the use of existing antibiotics is an important strategy in efforts to address the escalating antimicrobial resistance crisis. We report a new approach to the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections by demonstrating that oxacillin can be used to significantly attenuate the virulence of MRSA despite the pathogen being resistant to this drug. Using mechanistic in vitro assays and in vivo models of invasive pneumonia and sepsis, we show that oxacillin-treated MRSA strains are significantly attenuated in virulence. This effect is based primarily on the oxacillin-dependent repression of the accessory gene regulator quorum-sensing system and altered cell wall architecture, which in turn lead to increased susceptibility to host killing of MRSA. Our data indicate that β-lactam antibiotics should be included in the treatment regimen as an adjunct antivirulence therapy for patients with MRSA infections. This would represent an important change to current clinical practice for treatment of MRSA infection, with the potential to significantly improve patient outcomes in a safe, cost-effective manner.

1 September 2017 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
LGLaura A. Gallagher
Laura A. Gallagher
SCSimone Coughlan
Simone Coughlan
NBNikki S. Black
Nikki S. Black
PLPierce Lalor
Pierce Lalor
EWElaine M. Waters
Elaine M. Waters
JOJim O'Gara
Jim O'Gara
Hospital-associated methicillin-resistant Staphylococcus aureus (MRSA) strains typically express high-level, homogeneous (HoR) β-lactam resistance, whereas community-associated MRSA (CA-MRSA) more commonly express low-level heterogeneous (HeR) resistance. Expression of the HoR phenotype typically requires both increased expression of the mecA gene, carried on the staphylococcal cassette chromosome mec element (SCC mec ), and additional mutational event(s) elsewhere on the chromosome. Here the oxacillin concentration in a chemostat culture of the CA-MRSA strain USA300 was increased from 8 μg/ml to 130 μg/ml over 13 days to isolate highly oxacillin-resistant derivatives. A stable, small-colony variant, designated HoR34, which had become established in the chemostat culture was found to have acquired mutations in gdpP , clpX , guaA , and camS . Closer inspection of the genome sequence data further revealed that reads covering SCC mec were ∼10 times overrepresented compared to other parts of the chromosome. Quantitative PCR (qPCR) confirmed >10-fold-higher levels of mecA DNA on the HoR34 chromosome, and MinION genome sequencing verified the presence of 10 tandem repeats of the SCC mec element. qPCR further demonstrated that subculture of HoR34 in various concentrations of oxacillin (0 to 100 μg/ml) was accompanied by accordion-like contraction and amplification of the SCC mec element. Although slower growing than strain USA300, HoR34 outcompeted the parent strain in the presence of subinhibitory oxacillin. These data identify tandem amplification of the SCC mec element as a new mechanism of high-level methicillin resistance in MRSA, which may provide a competitive advantage for MRSA under antibiotic selection.